Press Releases and Bulletins

ASRM Remembers Paul McDonough, M.D.

We are saddened to have learned of the passing of Dr. Paul McDonough on May 8, 2021 in Augusta, Georgia. A past president of ASRM (1989-1990) and giant in the field of reproductive medicine, Dr. McDonough leaves a legacy of distinguished work and contributions to the advancement of science.

Statement from the ASRM COVID-19 Task Force

For over a year, we have been working to evaluate the latest science around COVID-19 and reproductive health.

As scientists and medical experts conduct and analyze the research, we have refined our recommendations accordingly. As in all our work, we endeavor to help professionals and patients understand the best information available.

ASRM Applauds Administration Decision to Continue Fetal Tissue Research

The American Society for Reproductive Medicine (ASRM) applauds the decision from the National Institutes of Health (NIH)to continue to allow federally funded researchers to work with tissues and cell lines originally derived from fetal tissue. As we have seen with the development of the COVID-19 vaccines and therapeutics, the impact of these materials as research tools is broad, and essential.

Ricardo Azziz to step down as ASRM CEO; longtime COO Vickie Gamble to serve as interim CEO through 2021

Hugh Taylor MD, President of the American Society for Reproductive Medicine, today announced the resignation of CEO Ricardo Azziz MD, MBA, MPH effective June 30, 2021. Vickie Gamble, ASRM’s long-term Chief Operating Officer, will serve as interim CEO through the remainder of 2021. “We want to thank Dr. Azziz for his skillful leadership during what was certainly one of the most challenging times in our 77-year history”, said Dr. Taylor. “When searching for a CEO in 2019, we did not have “…ability to manage during a global pandemic” in the job description, but that is exactly what Dr. Azziz has had to do.” Dr. Azziz, remarked, “It has been my great honor leading the ASRM, an organization for which I have great respect, during these trying times, all with the goal of making the ASRM a stronger, more sustainable, and more relevant organization.”

Embryo Transfer Simulator Provides Fellows Practice for over 120 Simulated Transfers and Increases Physician Self-Confidence By 125%

The American Society for Reproductive Medicine (ASRM) announced today that embryo transfer simulation produced a 125% increase in physician self-confidence. As part of a two-day education course, fellows practiced more than 20 simulated embryo transfers, better equipping them to be confident and competent in the clinical environment. This finding is published in ASRM’s journal, Fertility and Sterility.

More than 77 Thousand Babies Born from ART

The Society for Assisted Reproductive Technology, the United States’ primary organization of professionals dedicated to the practice of assisted reproductive technologies (ART) is releasing its latest national and clinic-specific ART data, today. The preliminary national data set for 2019 shows 77,256 babies born resulting from 302,998 cycles performed during that year, an increase from the previous year’s number of 74,590 babies born from 279,288 cycles. 361 SART member clinics contributed to the report.

ASRM COVID-19 Task Force Issues Update No. 14

In the current update, the ASRM Coronavirus/COVID-19 Task Force (the “Task Force”) continues to support both vaccination with currently available vaccines for all individuals, including women who are either pregnant or contemplating conception (see Update #11), and continued strict adherence to its earlier recommended mitigation strategies for disease prevention, including use of social distancing, and rigorous attention to hand washing, Personal Protective Equipment (PPE), especially masking, and quarantines when appropriate (see Update #3). In addition, the Task Force is issuing this update to assist reproductive care specialists in counseling their patients and their communities regarding vaccination, including vaccination in pregnancy, and to provide considerations for relaxing restrictions.

ASRM Ethics Committee Chair Co-Authors Science Article - Argues to Revisit the “14-Day Limit” on Human Embryo Research

Sigal Klipstein, MD, Chair of the ASRM Ethics Committee, co-authored an article appearing in the most recent issue of Science. The article entitled, “Human embryo research beyond the primitive streak,” explores the question of whether it is time to rethink the historical prohibition, now 40 years old, of culturing human embryos for research beyond 14 days consecutive or growth, or beyond the development of the primitive streak.

Update No. 13 – Variants, Vaccines, and Vaccination

Even though the decreasing trend in infection rates is encouraging, and 52 million in the U.S. have been vaccinated, CDC guidelines should be strictly followed, and COVID-19 prevention should remain a top priority to reduce the likelihood of the emergence of additional, new SARS-CoV-2 variants. While COVID-19 vaccines are highly effective in preventing illness and hospitalization, their effectiveness for prevention of transmission remains unclear. Care centers should continue to maintain usage of masks and double masking, hand washing, avoidance of crowds, and social distancing.
is a patient education website of ASRM.